Intuitive Surgical, Inc. (NASDAQ:ISRG) was downgraded by Vetr from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday. They currently have a $1,006.51 target price on the medical equipment provider’s stock. Vetr‘s price objective points to a potential upside of 2.15% from the company’s current price.

ISRG has been the subject of a number of other research reports. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price target for the company in a report on Monday, April 24th. Wedbush increased their target price on Intuitive Surgical from $835.00 to $875.00 and gave the stock an “outperform” rating in a report on Monday, April 24th. Leerink Swann reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, July 5th. Morgan Stanley reaffirmed an “overweight” rating and set a $1,070.00 target price (up previously from $950.00) on shares of Intuitive Surgical in a report on Tuesday, July 25th. Finally, Barclays PLC increased their target price on Intuitive Surgical from $870.00 to $1,000.00 and gave the stock an “overweight” rating in a report on Friday, July 21st. They noted that the move was a valuation call. Seven investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $979.79.

Shares of Intuitive Surgical (NASDAQ ISRG) opened at 985.37 on Wednesday. Intuitive Surgical has a 12 month low of $610.71 and a 12 month high of $990.44. The stock’s 50 day moving average price is $942.88 and its 200 day moving average price is $840.08. The firm has a market cap of $36.61 billion, a price-to-earnings ratio of 47.20 and a beta of 0.39. Intuitive Surgical shares are going to split on the morning of Thursday, August 31st. The 3-1 split was announced on Friday, August 11th. The newly issued shares will be distributed to shareholders after the market closes on Wednesday, August 30th.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 EPS for the quarter, beating analysts’ consensus estimates of $5.79 by $0.16. The firm had revenue of $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. Intuitive Surgical’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.62 earnings per share. Equities research analysts predict that Intuitive Surgical will post $23.92 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.watchlistnews.com/intuitive-surgical-inc-isrg-stock-rating-lowered-by-vetr-inc/1492824.html.

In other news, CEO Gary S. Guthart sold 17,975 shares of the stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $937.27, for a total transaction of $16,847,428.25. Following the sale, the chief executive officer now directly owns 101,798 shares in the company, valued at approximately $95,412,211.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 1,000 shares of the stock in a transaction that occurred on Wednesday, May 31st. The stock was sold at an average price of $917.27, for a total value of $917,270.00. Following the sale, the director now owns 3,787 shares in the company, valued at $3,473,701.49. The disclosure for this sale can be found here. Insiders have sold a total of 34,065 shares of company stock worth $31,659,090 over the last quarter. Insiders own 2.50% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Koch Industries Inc. boosted its stake in shares of Intuitive Surgical by 202,917.0% in the second quarter. Koch Industries Inc. now owns 1,388,636 shares of the medical equipment provider’s stock worth $1,387,000 after buying an additional 1,387,952 shares during the last quarter. 1st Global Advisors Inc. boosted its stake in shares of Intuitive Surgical by 0.7% in the second quarter. 1st Global Advisors Inc. now owns 1,035 shares of the medical equipment provider’s stock worth $968,000 after buying an additional 7 shares during the last quarter. Piedmont Investment Advisors LLC boosted its stake in shares of Intuitive Surgical by 1,094.0% in the second quarter. Piedmont Investment Advisors LLC now owns 8,406 shares of the medical equipment provider’s stock worth $7,863,000 after buying an additional 7,702 shares during the last quarter. Wilbanks Smith & Thomas Asset Management LLC boosted its stake in shares of Intuitive Surgical by 0.5% in the second quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 370 shares of the medical equipment provider’s stock worth $346,000 after buying an additional 2 shares during the last quarter. Finally, Nomura Holdings Inc. boosted its stake in shares of Intuitive Surgical by 686.7% in the second quarter. Nomura Holdings Inc. now owns 2,730 shares of the medical equipment provider’s stock worth $2,543,000 after buying an additional 2,383 shares during the last quarter. Institutional investors and hedge funds own 96.08% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

To view Vetr’s full report, visit Vetr’s official website.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.